07:00 , Oct 4, 2010 |  BC Week In Review  |  Financial News

Amyris completes IPO

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing   Date completed: 9/28/10   Type: IPO   Raised: $84.8 million   Shares: 5.3 million   Price: $16   Shares after offering: 43 million   Underwriters: Morgan...
07:00 , Oct 4, 2010 |  BioCentury  |  Finance

Out and up

Out and up Industrial synthetic biology company Amyris Inc. (NASDAQ:AMRS) may not have hit the numbers it hoped for in its IPO last week, but it didn't disappoint in the after-market, either. On Tuesday, the...
23:45 , Sep 28, 2010 |  BC Extra  |  Financial News

Amyris raises $84.8M in IPO

Amyris Inc. (NASDAQ:AMRS) raised $84.8 million through the sale of 5.3 million shares at $16 in an IPO underwritten by Morgan Stanley; JPMorgan; Goldman Sachs; Banco Itau; and Stifel Nicolaus Weisel. The deal came in...
07:00 , Sep 20, 2010 |  BC Week In Review  |  Financial News

Amyris amends IPO

Amyris Biotechnologies Inc. , Emeryville, Calif.   Business: Biomanufacturing   Date announced: 9/13/10   Type: IPO   To be raised: Up to $121.9 million   Shares: 5.3 million   Price: $18-$20   Underwriters: Morgan Stanley;...
07:00 , Sep 20, 2010 |  BioCentury  |  Finance

Industrial Synthesis

Amyris Biotechnologies Inc. , which launched its IPO roadshow last week, got its start in therapeutics, but now is focused on using synthetic biology to produce fuels and chemicals such as surfactants, lubricants and synthetic...
23:50 , Sep 14, 2010 |  BC Extra  |  Financial News

Amyris amends IPO

Amyris Biotechnologies Inc. (Emeryville, Calif.) amended its IPO and hopes to sell 5.3 million shares at $18-$20. A $19 price would raise $100.7 million and value the company at $768.2 million. In April, Amyris filed...
07:00 , Apr 26, 2010 |  BC Week In Review  |  Financial News

Amyris proposes IPO

Amyris Biotechnologies Inc. , Emeryville, Calif.   Business: Biomanufacturing   Date announced: 4/16/10   Type: IPO   To be raised: Up to $100 million   Shares: TBD   Price: TBD   Underwriters: Morgan Stanley; JPMorgan;...
07:00 , Apr 26, 2010 |  BioCentury  |  Finance

Back in the game

Two U.S. IPOs each raised more than $70 million last week, making them the first big IPOs since oncology play Aveo Pharmaceuticals Inc. (NASDAQ: AVEO) raised $81 million on March 1. Ophthalmic company Alimera Sciences...
01:27 , Apr 20, 2010 |  BC Extra  |  Financial News

Amyris files for IPO

Amyris Biotechnologies Inc. (Emeryville, Calif.) filed to raise up to $100 million in an IPO underwritten by Morgan Stanley; JPMorgan; Goldman Sachs; Banco Itau; and Thomas Weisel Partners. Amyris uses synthetic biology to engineer microbes...